PATENT CLAIM ANALYSIS

Application Number: 15927170
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "230500"]

Abstract:
The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

Claim (Index 21):
The method of  claim 1 , wherein R 5  is H, 1-methyl-1H-pyrazol-4-yl, 2-furyl, CN, NO 2 , methoxy, \u2014C(\u2550O)NH 2 , \u2014C(\u2550O)NH(CH 3 ), \u2014C(\u2550O)N(CH 3 ) 2 , \u2014C(\u2550O)-(morpholin-4-yl), \u2014C(\u2550O)CH 3 , \u2014CH 2 OH, \u2014CH 2 OCH 3 , \u2014CH 2 NH 2 , \u2014CH 2 NHSO 2 (CH 2 CH 3 ), \u2014CH 2 NHC(\u2550O)CH 3 , \u2014CH(OH)CH 3 , \u2014SO 2 CH 3 , \u2014SO 2 CH 2 CH 3 , \u2014SO 2 -(isopropyl), \u2014SO 2 N(CH 3 ) 2 , \u2014SO 2 NH(CH 3 ), \u2014SO 2 \u2014NH(isopropyl), or \u2014SO 2 -(piperidin-1-yl).

Metadata:
- Claim Count in Document: 126.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14554306', '15354223', '15088373', '14554263', '15906163']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8529325714501794
- 35 USC 102 Novelty (BERT): 0.6174385266485896
- Combined Prediction Score: 0.8293831669700205
- Mean Citation Score: 555.065632
- Max Citation Score: 614.763
- Similarity Product: 494.506432848394

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test